These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Methods of analysis of dendritic cell-derived exosome-shuttle microRNA and its horizontal propagation between dendritic cells. Montecalvo A; Larregina AT; Morelli AE Methods Mol Biol; 2013; 1024():19-40. PubMed ID: 23719940 [TBL] [Abstract][Full Text] [Related]
9. Exosomal RNA as biomarkers and the therapeutic potential of exosome vectors. Lässer C Expert Opin Biol Ther; 2012 Jun; 12 Suppl 1():S189-97. PubMed ID: 22506888 [TBL] [Abstract][Full Text] [Related]
10. The role of exosomes and "exosomal shuttle microRNA" in tumorigenesis and drug resistance. Zhao L; Liu W; Xiao J; Cao B Cancer Lett; 2015 Jan; 356(2 Pt B):339-46. PubMed ID: 25449429 [TBL] [Abstract][Full Text] [Related]
11. Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer. Singh R; Pochampally R; Watabe K; Lu Z; Mo YY Mol Cancer; 2014 Nov; 13():256. PubMed ID: 25428807 [TBL] [Abstract][Full Text] [Related]
12. Cell-secreted vesicles in equine ovarian follicular fluid contain miRNAs and proteins: a possible new form of cell communication within the ovarian follicle. da Silveira JC; Veeramachaneni DN; Winger QA; Carnevale EM; Bouma GJ Biol Reprod; 2012 Mar; 86(3):71. PubMed ID: 22116803 [TBL] [Abstract][Full Text] [Related]
13. Cardiac Myocyte Exosome Isolation. Malik ZA; Liu TT; Knowlton AA Methods Mol Biol; 2016; 1448():237-48. PubMed ID: 27317185 [TBL] [Abstract][Full Text] [Related]
14. Targeted therapeutic delivery using engineered exosomes and its applications in cardiovascular diseases. Xitong D; Xiaorong Z Gene; 2016 Jan; 575(2 Pt 2):377-384. PubMed ID: 26341056 [TBL] [Abstract][Full Text] [Related]
15. Analysis of viral microRNA exchange via exosomes in vitro and in vivo. Verweij FJ; van Eijndhoven MA; Middeldorp J; Pegtel DM Methods Mol Biol; 2013; 1024():53-68. PubMed ID: 23719942 [TBL] [Abstract][Full Text] [Related]
16. Towards analyzing the potential of exosomes to deliver microRNA therapeutics. Giassafaki LN; Siqueira S; Panteris E; Psatha K; Chatzopoulou F; Aivaliotis M; Tzimagiorgis G; Müllertz A; Fatouros DG; Vizirianakis IS J Cell Physiol; 2021 Feb; 236(2):1529-1544. PubMed ID: 32749687 [TBL] [Abstract][Full Text] [Related]
17. Exosomes and the emerging field of exosome-based gene therapy. O'Loughlin AJ; Woffindale CA; Wood MJ Curr Gene Ther; 2012 Aug; 12(4):262-74. PubMed ID: 22856601 [TBL] [Abstract][Full Text] [Related]
18. Microfluidic fabrication of cell-derived nanovesicles as endogenous RNA carriers. Jo W; Jeong D; Kim J; Cho S; Jang SC; Han C; Kang JY; Gho YS; Park J Lab Chip; 2014 Apr; 14(7):1261-9. PubMed ID: 24493004 [TBL] [Abstract][Full Text] [Related]
19. The role of exosomes and miRNAs in drug-resistance of cancer cells. Bach DH; Hong JY; Park HJ; Lee SK Int J Cancer; 2017 Jul; 141(2):220-230. PubMed ID: 28240776 [TBL] [Abstract][Full Text] [Related]
20. Exosomes for mRNA delivery: a novel biotherapeutic strategy with hurdles and hope. Aslan C; Kiaie SH; Zolbanin NM; Lotfinejad P; Ramezani R; Kashanchi F; Jafari R BMC Biotechnol; 2021 Mar; 21(1):20. PubMed ID: 33691652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]